03:49 PM EST, 02/07/2025 (MT Newswires) -- Entero Therapeutics ( ENTO ) got a $2 million revolving loan and appointed three new board members designated by the undisclosed lender as a condition for the funding.

Richard Paolone, Eric Corbett and Manpreet Uppal replaced James Sapirstein, Alastair Riddell and Timothy Ramdeen on the board, the company said Friday in a statement.

The board has five members. Sapirstein is chief executive officer of Entero.

Price: 0.55, Change: +0.03, Percent Change: +6.54